Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - heparin sodium, quantity: 1000 iu/l - injection, solution - excipient ingredients: sodium chloride; citric acid monohydrate; dibasic sodium phosphate dodecahydrate; water for injections - indications as at 11 july 2003: heparin sodium in 0.9% sodium chloride intravenous infusion is indicated as an anticoagulant in extracorporeal circulation, dialysis procedures, and as an aid in the maintenance of catheter patency.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

unimed sdn bhd - sodium chloride (salt); dextrose, anhydrous/anhydrous glucose; sodium citrate/trisodium citrate; potassium chloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

hameln pharma pty ltd - oxycodone hydrochloride, quantity: 10 mg - injection, solution - excipient ingredients: sodium citrate dihydrate; sodium hydroxide; sodium chloride; hydrochloric acid; water for injections; citric acid monohydrate - oxycodone-hameln solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

hameln pharma pty ltd - oxycodone hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: citric acid monohydrate; sodium chloride; hydrochloric acid; sodium citrate dihydrate; water for injections; sodium hydroxide - oxycodone-hameln solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - citric acid 12.2 g; magnesium carbonate monohydrate 7.4 g; sodium picosulfate 10.3mg - powder for oral solution - active: citric acid 12.2 g magnesium carbonate monohydrate 7.4 g sodium picosulfate 10.3mg excipient: orange flavour facb076 sweetener sweetesse 97 - picoprep orange is indicated for bowel emptying and cleansing by means of total gastrointestinal tract perfusion in preparation for gastrointestinal examination (such as colonoscopy, barium enema x-ray examination), prior to intravenous pyelograms (ivp) or colorectal surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - posaconazole, quantity: 40 mg/ml - oral liquid, suspension - excipient ingredients: sodium benzoate; sodium citrate dihydrate; citric acid monohydrate; titanium dioxide; glycerol; xanthan gum; liquid glucose; peg-40 hydrogenated castor oil; purified water; peg-40 stearate; benzoic acid; glyceryl monostearate; methylcellulose; polysorbate 65; simethicone; sorbic acid; sulfuric acid; flavour - posaconazole is indicated for use in the treatment of the following invasive fungal infections in patients 13 years of age or older: ? invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy. ? fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy.,posaconazole is also indicated for the: ? treatment of oropharyngeal candidiasis in immunocompromised adults, including patients with disease that is refractory to itraconazole and fluconazole. ? prophylaxis of invasive fungal infections among patients 13 years of age and older, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (hsct) recipients.

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - sodium citrate glucose citric acid monohydrate sodium acid phosphate - 26.3 grams

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - sodium citrate glucose citric acid sodium acid phosphate -

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - citric acid 12.77 mg/g; macrogol 3350 755.68 mg/g (as macrogol 3350 prepared solution contains 6% w/w); potassium chloride 10.55 mg/g; sodium chloride 37.33 mg/g;  ; sodium sulfate 80.62 mg/g; citric acid 771.868 mg/g; heavy magnesium oxide 225.128 mg/g; sodium picosulfate 0.64 mg/g - combination - active: citric acid 12.77 mg/g macrogol 3350 755.68 mg/g (as macrogol 3350 prepared solution contains 6% w/w) potassium chloride 10.55 mg/g sodium chloride 37.33 mg/g   sodium sulfate 80.62 mg/g excipient: ascorbic acid aspartame lemon flavour ql58817 active: citric acid 771.868 mg/g heavy magnesium oxide 225.128 mg/g sodium picosulfate 0.64 mg/g excipient: aspartame - indicated for bowel emptying and cleansing by means of total gastrointestinal tract perfusion in preparation for gastrointestinal examination

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - sodium chloride, potassium chloride, sodium bicarbonate, citric acid, aminoacetic acid, lactose monohydrate ph.eur. - tablets effervescent - unknown - electrolyte solutions - bovine - electrolytes